News Center

WCG KMR Group Invites Biopharmaceutical Companies to Enroll in Clinical Trial Cost Study

Study will yield reliable benchmarks on trial cost and efficiency, enabling participants to realize dramatic cost savings Princeton, NJ – September 17, 2019 – The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division is pleased to announce that enrollment in WCG KMR Group’s 2019 Clinical Trial Cost Study is now open. Currently in its fourth year, the […]

Donald A. Deieso, PhD: One of PharmaVOICE’s 100 Most Inspiring Leaders of 2019

WCG’s Executive Chairman and CEO is two-time recipient of top honor Princeton, NJ – September 10, 2019 – The WIRB-Copernicus Group® (WCG™) announced that its Executive Chairman and Chief Executive Officer (CEO), Donald A. Deieso, PhD, has been named one of the 100 Most Inspiring Leaders in the Life Science Industry by PharmaVOICE for the […]

WCG Introduces Velos eResearch eXpress™

Turn-key solution for the sustainable advancement and growth of clinical research sites  Princeton, NJ – August 27, 2019 – The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division introduces Velos eResearch eXpress™, an out-of-the-box, cloud-based solution that enables clinical research sites to centralize and manage their research activities on a single, automated technology platform.  Velos eResearch eXpress provides […]

WCG Acquires PharmaSeek, LLC

WCG welcomes leading provider of administrative, consulting and training solutions for clinical research sites Princeton, NJ – August 8, 2019 – The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced the acquisition of PharmaSeek, LLC, including its wholly-owned subsidiaries PFS Clinical and PatientWise, leading providers of turn-key administrative, consulting, patient recruitment and training solutions for clinical […]

WCG Introduces New Benchmarking Consortium to Optimize Vaccine Development

WCG’s KMR Group uses unparalleled data to evaluate performance, examine industry trends, and highlight best practices for those who research and develop vaccines Princeton, NJ – July 29, 2019 – The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division will offer its unique data-driven benchmarking solution to companies that discover and develop vaccines, helping them to increase […]

WCG Introduces Unique Benchmarking Solution for Medical Device Companies

WCG’s KMR Group uses unparalleled data to accelerate study start-up in clinical trials Princeton, NJ – May 29, 2019 – The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division will offer its unique data-driven benchmarking solution to medical device companies, helping them to accelerate study start-up in clinical trials. The solution has already enabled over 27 of […]

WCG to Lead Educational Session on Implementing the Revised Common Rule at AAHRPP Annual Conference

Focus will be on new information that needs to be included in informed consent materials for clinical trials

WCG Expands its Research Site Executive Team, Global Research Network

Company focuses on energizing and empowering investigative sites that support clinical research Princeton, NJ – April 12, 2019 – The WIRB-Copernicus Group® (WCG™) is pleased to announce the addition of several prominent executives to its Site Division and the expansion of its Global Research Network™ (GRN) of investigative sites. WCG is the leader in supporting […]

WCG to Feature Site‐Specific Solutions at ACRP 2019

Company to highlight expanded focus on investigative sites at Annual Meeting of the Association of Clinical Research Professionals (ACRP) Princeton, NJ – April 10, 2019 – The WIRB-Copernicus Group’s® (WCG™) Site Division is pleased to announce its participation in the Annual Meeting of the Association of Clinical Research Professionals (ACRP) on April 12-15, 2019 in […]

WCG Announces the Acquisition of Analgesic Solutions, LLC

WCG welcomes leading provider of solutions that improve the quality of clinical trials in pain management Princeton, NJ – April 4, 2019 – The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announces the acquisition of Analgesic Solutions, LLC, the global leader in the development of new pain medications and in the support of clinical trials in […]